| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-10 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.35 | 8e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |